Acessibilidade / Reportar erro
This erratum corrects:

Erratum on "Non-indolent mantle cell lymphoma at a single public hospital in Brazil: real world first-line treatment cohort study data"

In the article “Non-indolent mantle cell lymphoma at a single public hospital in Brazil: real world firstline treatment cohort study data”, with DOI number: https://doi.org/10.1016/j.htct.2018.12.003, published in Hematol Transfus Cell Ther. 2020;42(1):93–97, Figure 2 is duplicated, therefore, where itreads:

"The SCG and NSCG overall survival were 12 months and 9.6 months, respectively, and these data were not statistically significant (Figures 2 and 3)."

It should read:

The SCG and NSCG overall survival were 12 months and 9.6 months, respectively, and these data were not statistically significant (Figure 2).

And where it reads:

"In comparison, the SCG and NSCG overall survival results were not statistically significant, which means that with the disposable chemotherapy armamentarium, whatever efforts we make, the results are quite the same, regardless of patient fitness or age (Figure 3)."

It should read:

"In comparison, the SCG and NSCG overall survival results were not statistically significant, which means that with the disposable chemotherapy armamentarium, whatever efforts we make, the results are quite the same, regardless of patient fitness or age (Figure 2)."

Publication Dates

  • Publication in this collection
    24 July 2020
  • Date of issue
    Apr-Jun 2020
Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular (ABHH) R. Dr. Diogo de Faria, 775 cj 133, 04037-002, São Paulo / SP - Brasil - São Paulo - SP - Brazil
E-mail: htct@abhh.org.br